trending Market Intelligence /marketintelligence/en/news-insights/trending/uogclqddc4m1zrlf1vym2q2 content esgSubNav
In This List

MiMedx gets another Nasdaq noncompliance notice

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

MiMedx gets another Nasdaq noncompliance notice

MiMedx Group Inc. received another noncompliance notice from the Nasdaq stock market for failing to file a periodic report.

The Marietta, Ga.-based company is yet to file its quarterly earnings report for the three months ended March 31.

MiMedx previously received a Nasdaq notice for failing to file its annual report for the year ended Dec. 31, 2017. The company, which develops regenerative biomaterial products and bioimplants, has submitted to Nasdaq a plan to regain compliance.

The Nasdaq notice has no immediate effect on the listing of the company's common stock.